The new office in China will allow for direct presences in the Chinese market, which will enhance the company’s local capabilities, according to the report. The new branch will initially focus on the neurosurgical business, but the company plans to introduce products from the spine and orthobiologics market as well.
Related Articles on Orthopedic Device Companies:
Mazor Sells Three U.S. Robotic Spine Systems in 3Q, Reports $1.6M in Revenue
Medtronic Launches T2 Altitude Expandable Corpectomy Device
ArthroCare to Settle Private Securities Class Action Suit
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.